Related Articles
Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer
Astaxanthin inhibits gemcitabine‑resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization
Preclinical rationale for synergistic interaction of pemetrexed and cytotoxic nucleoside analogues
Ribonucleotide reductase subunit M1 assessed by quantitative double-fluorescence immunohistochemistry predicts the efficacy of gemcitabine in biliary tract carcinoma
FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1